|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.814
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.632
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.626
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.621
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.562
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.550
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.531
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.511
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.503
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.497
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.446
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.444
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.433
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.399
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.391
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.376
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.374
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.352
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.352
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.348
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.347
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.319
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.317
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.307
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.302
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.298
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.286
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.284
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.281
|
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.277
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.265
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.263
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.260
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.257
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.253
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.252
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.252
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.251
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.251
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.250
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.243
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.243
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.238
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.234
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.229
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.227
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.221
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.217
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.213
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.206
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.201
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.201
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.201
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.200
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.194
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.194
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.193
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.192
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.190
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.186
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.181
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.178
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.174
|
|
|
|
triglyceride rich lipoprotein particle remodeling
|
GO:0034370 |
2 |
0.173
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.168
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.167
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.164
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.163
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.160
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.157
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.154
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.152
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.151
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.150
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.146
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.145
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.142
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.140
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.139
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.137
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.130
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.128
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.128
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.126
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.124
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.124
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.121
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.121
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.120
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.120
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.119
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.118
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.118
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.116
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.114
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.114
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.112
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.110
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.110
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.109
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.108
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.108
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.105
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.104
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.104
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.104
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.103
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.103
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.102
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.101
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.101
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.098
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.095
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.094
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.094
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.093
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.093
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.093
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.092
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.092
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.090
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.089
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.088
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.088
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.088
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.086
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.084
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.083
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.083
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.082
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.082
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.081
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.081
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.081
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.080
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.079
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.079
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.078
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.077
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.076
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.075
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.075
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.074
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.073
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.073
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.073
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.072
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.072
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.071
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.071
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.071
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.070
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.070
|
|
|
|
response to cadmium ion
|
GO:0046686 |
8 |
0.069
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.069
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.069
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.069
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.068
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.068
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.068
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.068
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.066
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.066
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.065
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.064
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.064
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.064
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.064
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.063
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.062
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.061
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.061
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.061
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.061
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.061
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.060
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.060
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.059
|
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.059
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.059
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.058
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.058
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.058
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.057
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.056
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.056
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.056
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.054
|
|
|
|
positive regulation of systemic arterial blood pressure
|
GO:0003084 |
9 |
0.054
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.054
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.054
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.054
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.054
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.054
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.054
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.051
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.051
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.051
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.051
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.051
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.050
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.050
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.050
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.050
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.050
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.049
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.049
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.048
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.048
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.047
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.047
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.047
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.047
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.046
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.046
|
|
|
|
toxin metabolic process
|
GO:0009404 |
5 |
0.046
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.046
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.046
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.046
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.045
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.045
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.045
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.045
|
|
|
|
trabecular meshwork development
|
GO:0002930 |
2 |
0.044
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.044
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.044
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.044
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.043
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.043
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.043
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.043
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.043
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.042
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.042
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.042
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.042
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.042
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.042
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.042
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.041
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.040
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.040
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.040
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.040
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.038
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.038
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.038
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.038
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.037
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.037
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.037
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.036
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.036
|
|
|
|
negative regulation of endothelial cell proliferation
|
GO:0001937 |
8 |
0.036
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.036
|
|
|
|
linoleic acid metabolic process
|
GO:0043651 |
6 |
0.036
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.036
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.035
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.035
|
|
|
|
protein lipid complex remodeling
|
GO:0034368 |
6 |
0.035
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.035
|
|
|
|
cholesterol catabolic process
|
GO:0006707 |
5 |
0.035
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.035
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.035
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.035
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.035
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.034
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.034
|
|
|
|
learning
|
GO:0007612 |
98 |
0.034
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.034
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.034
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.034
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.034
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.034
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.034
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.034
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.033
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.033
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.033
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.033
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.033
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.033
|
|
|
|
positive regulation of triglyceride lipase activity
|
GO:0061365 |
3 |
0.032
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.032
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.032
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.032
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.032
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.032
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.032
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.032
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.032
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.032
|
|
|
|
fatty acid transmembrane transport
|
GO:1902001 |
1 |
0.032
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.032
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.031
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.031
|
|
|
|
positive regulation of estrogen secretion
|
GO:2000863 |
1 |
0.031
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.031
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.031
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.031
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.031
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.031
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.031
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.031
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.030
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.030
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.030
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.030
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.030
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.030
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.030
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.030
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.030
|
|
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
0.030
|
|
|
|
regulation of dopamine secretion
|
GO:0014059 |
9 |
0.030
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.030
|
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
19 |
0.030
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.030
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.029
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.029
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.029
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.029
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.029
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.029
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.029
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.028
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.028
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.028
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.028
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.028
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.027
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.027
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.027
|
|
|
|
estrogen secretion
|
GO:0035937 |
1 |
0.027
|
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.027
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.027
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.027
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.026
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.026
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.026
|
|
|
|
negative regulation of cell adhesion mediated by integrin
|
GO:0033629 |
2 |
0.026
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.026
|
|
|
|
primary alcohol metabolic process
|
GO:0034308 |
11 |
0.025
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.025
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.025
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.025
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.025
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.025
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.025
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.025
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.025
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.025
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.025
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.025
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.025
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.025
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.025
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.025
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.025
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.024
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.024
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.024
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.024
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.024
|
|
|
|
very low density lipoprotein particle remodeling
|
GO:0034372 |
1 |
0.023
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.023
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.023
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.023
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.023
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.023
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
12 |
0.023
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.023
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.023
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.023
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.022
|
|
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.022
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.022
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.022
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.022
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.022
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.022
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.022
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.022
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.022
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.022
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.022
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.021
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.021
|
|
|
|
positive regulation of hemostasis
|
GO:1900048 |
10 |
0.021
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.021
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.021
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
8 |
0.021
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.021
|
|
|
|
9 cis retinoic acid metabolic process
|
GO:0042905 |
5 |
0.021
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.021
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.020
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.020
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.020
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.020
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.020
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
13 |
0.020
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.020
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.020
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.020
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.019
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.019
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.019
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.019
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.019
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.019
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.019
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.019
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.019
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.019
|
|
|
|
temperature homeostasis
|
GO:0001659 |
26 |
0.019
|
|
|
|
cellular respiration
|
GO:0045333 |
38 |
0.019
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.019
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.019
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.019
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.019
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.019
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.019
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.019
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.019
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.019
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.018
|
|
|
|
response to food
|
GO:0032094 |
17 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.018
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.018
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.018
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.018
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
25 |
0.018
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.018
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.018
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.018
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.018
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.017
|
|
|
|
protein oxidation
|
GO:0018158 |
2 |
0.017
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.017
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.017
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.017
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.017
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.017
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.017
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.017
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.017
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.017
|
|
|
|
regulation of cell adhesion mediated by integrin
|
GO:0033628 |
13 |
0.017
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.017
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.017
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.017
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.017
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.017
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.017
|
|
|
|
cellular response to food
|
GO:0071240 |
1 |
0.016
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.016
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.016
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.016
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.016
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.016
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.016
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.016
|
|
|
|
fatty acid beta oxidation
|
GO:0006635 |
16 |
0.016
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.016
|
|
|
|
regulation of endocrine process
|
GO:0044060 |
13 |
0.016
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.016
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.016
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.016
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.016
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.016
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.016
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.015
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.015
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.015
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.015
|
|
|
|
sterol catabolic process
|
GO:0016127 |
5 |
0.015
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.015
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.015
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.015
|
|
